´ëÇÑ°íÇ÷¾ÐÇÐȸ (¿ÀÇÁ¶óÀÎ) Á¦76ȸ ¼¿ï °³¿øÀÇ ¹× Àü°øÀÇ ¿¬¼ö°Á : 2021-12-19±³À°ÀÏÀÚ : 2021-12-19
±³À°Àå¼Ò : ¼¿ï ÄÜ·¡µå È£ÅÚ
±³À°ÁÖÁ¦ :
(¿ÀÇÁ¶óÀÎ) Á¦76ȸ ¼¿ï °³¿øÀÇ ¹× Àü°øÀÇ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : ±èÈñÁÖ
¿¬¶ôó : 02-565-3350
À̸ÞÀÏ :
ksh3@koreanhypertension.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 160¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í ´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¤È¸¿ø ¹«·áºñȸ¿ø »çÀüµî·Ï 2¸¸¿øºñȸ¿ø ÇöÀåµî·Ï 3¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 09:00~09:15 °íÇ÷¾Ð ù Áø´Ü½Ã ±Ç°í ÇؾßÇÏ´Â °Ë»ç ¹× °íÇ÷¾Ð¿¡ ÀÇÇÑ Àå±â¼Õ»ó(HMOD) ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 09:15~09:30 °íÇ÷¾ÐÀÇ ºñ¾à¹°Ä¡·á Á¤¿ì¹é(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 09:30~09:45 Ç÷¾Ð°ÇÏÁ¦ ó¹æÀÇ ¿øÄ¢ ¼ÕÀϼ®(°æÈñÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 09:45~10:00 ¸ñÇ¥ Ç÷¾Ð µµ´ÞÀ» À§ÇÑ ÀÏÂ÷Àû Àü·« Á¶ÀºÁÖ(°¡Å縯ÀÇ´ë)
Åä·Ð 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 10:00~10:20 Åä·Ð ½Å¼ºÈñ, Á¶Àͼº, ±è¿µÁø, ÁÂÈÆÁ¤(ÀÎÇÏÀÇ´ë, ¿¬¼¼ÀÇ´ë, ¼º¸ð³»°ú, ¼¿ïÁ¤ÅëÀÇ¿ø)
ÈÞ½Ä 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 10:20~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 10:40~10:55 °í·É/ÃÊ°í·É ȯÀÚÀÇ °íÇ÷¾Ð Ä¡·á ±è±¤ÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 10:55~11:10 °¡ÀÓ±â/ÀÓ»êºÎ ¹× °»³â±â ¿©¼ºÀÇ °íÇ÷¾Ð Ä¡·á ÃÖÁ¤Çö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 11:10~11:25 Áø·á½Ç ¹Û Ç÷¾ÐÀ» °í·ÁÇØ¾ß Çϴ ȯÀÚ (¼ÒÁ¦¸ñ:Ç÷¾Ð º¯µ¿¼ºÀÌ Å« ȯÀÚ) ¹ÚÀçÇü(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 11:25~11:40 »ó±Þ º´¿øÀ¸·Î Àü¿øÀÌ ÇÊ¿äÇÑ °íÇ÷¾Ð¼º ÀÀ±Þ ȯÀÚ ±è´ëÈñ(¿ï»êÀÇ´ë)
Åä·Ð 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 11:40~12:00 Åä·Ð ¹ÚÂù¼®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 12:00~12:30 Optimal Management of Patients with Angina Pectoris and Hypertension based on Recent Guideline ±Ç¼º¿í(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 12:30~13:00 Update on BP(Blood Pressure) control strategy in Asian Older Patients with Hypertension (STEP study) ¹®Á¤±Ù(°¡ÃµÀÇ´ë)
ÈÞ½Ä 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 13:00~13:10 ÈÞ½Ä ()
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 13:10~13:25 ´ç´¢º´ÀÌ µ¿¹ÝµÈ °íÇ÷¾Ð ȯÀÚ Á¤¿íÁø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 13:25~13:40 °íÁöÇ÷ÁõÀÌ µ¿¹ÝµÈ °íÇ÷¾Ð ȯÀÚ ±èÀ念(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 13:40~13:55 Çù½ÉÁõÀÌ µ¿¹ÝµÈ °íÇ÷¾Ð ȯÀÚ ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 13:55~14:10 ¸¸¼º ÄáÆÏÁúȯÀÌ µ¿¹ÝµÈ °íÇ÷¾Ð À¯½Â±â(À»ÁöÀÇ´ë)
Åä·Ð 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 14:10~14:30 Åä·Ð ¹Ú¿ëÇö, ½ÉÁö¿µ, ÀÌÁØ¿ì, ÃÖÀ±Á¾(ºÎ»êÀÇ´ë, ¿¬¼¼ÀÇ´ë, »ù³»°ú, ¿¬¼¼ÃÖ¼±³»°ú)
ÈÞ½Ä 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 14:30~14:50 ÈÞ½Ä ()
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 14:50~15:10 °íÇ÷¾Ð ÀÏÂ÷ ¸ñÇ¥·Î 130/80 mmHg°¡ ÀûÀýÇÑ°¡? (Intensive BP lowering strategy) ½ÅÁøÈ£(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 15:10~15:30 ¸ð¹ÙÀÏ Ç÷¾Ð ÃøÁ¤ÀÇ ÇöÀç¿Í ¹Ì·¡(Mobile BP as an out-of-office BP measurment) ÀÌÇØ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 15:30~15:50 ÀúÇ×¼º °íÇ÷¾ÐÀÇ ÃÖ½ÅÁö°ß(Update on management of resistant hypertension) ½Å¹Ì½Â(°¡ÃµÀÇ´ë)
Åä·Ð 12-19 ¼¿ï ÄÜ·¡µå È£ÅÚ 3Ãþ ±×·£µåº¼·ë 15:50~16:00 Åä·Ð ¹ÚÁغó, Á¶À翵, ·ùÀçÃá, ÀÌ»ó(¼¿ïÀÇ´ë, Àü³²ÀÇ´ë, ·ùÀçÃá³»°ú, ½º¸¶Æ®³»°ú)